Competitors Scramble to Catch Up with Novartis in Radiopharmaceuticals Industry

Drug developers are optimistic about the potential of delivering radiation directly to tumors as a groundbreaking advancement in cancer treatment. Pharmaceutical giants like Bristol Myers Squibb, AstraZeneca, and Eli Lilly

Detail

Positive results from midstage trial of Pfizer’s cancer cachexia drug

Pfizer announced positive results from a midstage trial of its experimental drug for cancer cachexia, a condition that causes cancer patients to lose weight and appetite. The drug, ponsegromab, showed

Detail

Major Cost Savings and Product Launches Ahead: $1 Billion in Cuts, 10 New Products on the Horizon

Moderna announced plans to slash $1.1 billion in expenses by 2027 and introduce new products following a decline in its Covid business. The biotech company aims for 10 new product

Detail